Skip to content

Clinical study on the difference between pulmonary metastases and primary lung tumors by radiomics

Clinical study on the difference between pulmonary metastases and primary lung tumors by radiomics

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400094801
Enrollment
Unknown
Registered
2024-12-27
Start date
2025-01-10
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung metastases

Interventions

Gold Standard:Pathological diagnosis
Index test:Deep Neural Network Model

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Age: 18-85 years old; 2. Patients with a history of extrapulmonary malignant tumors confirmed by pathology; 3. At least one pulmonary nodule with a diameter less than 30 mm found in CT examination in this hospital, including nodules found at the same time as the primary tumor and nodules found after the diagnosis of extrapulmonary tumors; 4. Complete clinical information and CT data.

Exclusion criteria

Exclusion criteria: 1. Patients with a history of lung surgery; 2. Patients with nodules found before the diagnosis of extrapulmonary tumors; 3. Patients with other lung diseases, such as pneumonia, pleural effusion, atelectasis.

Design outcomes

Primary

MeasureTime frame
Ssensitivity;Specificity;Accuracy;AUC,Area Under the Curve;

Countries

China

Contacts

Public ContactYunke Zhu

West China Hospital, Sichuan University

yunke_zhu@qq.com+86 189 8060 6152

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026